A Study to Determine the Safety and Efficacy in Lipoprotein Lipase-Deficient Subjects After Intramuscular Administration of AMT-011, an Adeno-Associated Viral Vector Expressing Human Lipoprotein LipaseS447X.

Trial Profile

A Study to Determine the Safety and Efficacy in Lipoprotein Lipase-Deficient Subjects After Intramuscular Administration of AMT-011, an Adeno-Associated Viral Vector Expressing Human Lipoprotein LipaseS447X.

Active, no longer recruiting
Phase of Trial: Phase II/III

Latest Information Update: 29 Sep 2011

At a glance

  • Drugs Alipogene tiparvovec; Ciclosporin; Mycophenolate mofetil
  • Indications Hyperlipoproteinaemia type I; Hypertriglyceridaemia
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Sponsors Amsterdam Molecular Therapeutics
  • Most Recent Events

    • 08 Dec 2010 New trial record
    • 17 Nov 2010 Results presented at the 83rd Annual Scientific Sessions of the American Heart Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top